Modifications of the Method for Calculating Absolute Drug Bioavailability

Purpose: Absolute bioavailability (F) is calculated as the ratio of the area under the plasma drug concentration-time curve (AUC) between extravascular administration and intravenous injection. However, as distribution of a drug after intravenous administration does not reach an equilibrium in the b...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Jiang (Author), Juan-juan Yang (Author), Lei Cao (Author), Xue Xiao (Author), Xiao-lian Shi (Author), Yong-xiao Cao (Author)
Format: Book
Published: Frontiers Media S.A., 2016-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a7a6e2fc25e04a6fa9b09a7f5372ef7e
042 |a dc 
100 1 0 |a Wei Jiang  |e author 
700 1 0 |a Juan-juan Yang  |e author 
700 1 0 |a Lei Cao  |e author 
700 1 0 |a Xue Xiao  |e author 
700 1 0 |a Xiao-lian Shi  |e author 
700 1 0 |a Yong-xiao Cao  |e author 
245 0 0 |a Modifications of the Method for Calculating Absolute Drug Bioavailability 
260 |b Frontiers Media S.A.,   |c 2016-05-01T00:00:00Z. 
500 |a 10.18433/J3RG78 
500 |a 1482-1826 
520 |a Purpose: Absolute bioavailability (F) is calculated as the ratio of the area under the plasma drug concentration-time curve (AUC) between extravascular administration and intravenous injection. However, as distribution of a drug after intravenous administration does not reach an equilibrium in the body during the distribution phase, the plasma drug concentration at this phase does not reflect the total amount of drug in the body. The goal of this paper was to analyze the insufficiencies of the method for calculating on absolute bioavailability and to propose a modification to improve the calculation. Methods: Literature reporting absolute bioavailability published during 1983-2014 was searched for ten drug candidates. Plasma drug concentrations representing the amount of drug in the body were then calculated at each time point during the distribution phase according to the plasma drug concentration-time relationship during the elimination phase. Results: The AUC values based on the distribution equilibrium drug concentrations following intravenous injection were 75%±11% of the actually measured drug concentrations in the literature. The absolute bioavailability values in the literature were 76%±12% of the actual bioavailability based on the AUCs from distribution-equilibrium drug concentrations. Conclusions: The present method underestimates the absolute drug bioavailability and should be modified to represent the data more accurately.   This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page. 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacy & Pharmaceutical Sciences, Vol 19, Iss 2 (2016) 
787 0 |n https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/27271 
787 0 |n https://doaj.org/toc/1482-1826 
856 4 1 |u https://doaj.org/article/a7a6e2fc25e04a6fa9b09a7f5372ef7e  |z Connect to this object online.